Illumina-ting AG Arguments in Support of Biotech Merger

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • A group of 12 Republican AGs filed an amicus brief asking the U.S. Court of Appeals for the Fifth Circuit to allow a merger to proceed between DNA sequencing company Illumina, Inc. and multi-cancer early detection test maker GRAIL, Inc.
  • The AGs argue in the brief that the integration of the companies will facilitate the swift market entry of GRAIL’s Galleri cancer screening technology.
  • As we previously reported, the FTC had ordered Illumina to divest GRAIL in April 2023, after finding that the acquisition would reduce competition in the U.S. market for cancer screening tests.
  • The AGs ask the Fifth Circuit to find that the FTC lacked the constitutional authority to order the divestiture, and to vacate the decision of the FTC Commissioners.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide